Toppari Jorma et al., In Reproductive Biology and Endocrinology, 2002
... Biotechnology, Inc., rabbit polyclonal antibodies against p107, SMADs (small mothers against decapentaplegic) 1/2/3, SMAD 4 and androgen receptor (positive control) from Santa Cruz Biotechnology, Inc., and a rabbit polyclonal ...
Li et al., Shenyang, China. In Int J Oncol, Feb 2016
UNASSIGNED: After the publication of the article, the authors decided to add the following grants in the Acknowledgements section: This study was supported by grants from the National Natural Science Foundation of China (Nos.
Mitsiades et al., Houston, United States. In Horm Cancer, Feb 2016
Despite the development and approval of new and more potent androgen synthesis inhibitors and androgen receptor (AR) antagonists, prostate cancers continue to develop resistance to these therapeutics, while often maintaining their dependence on the AR signaling axis.
He et al., Lanzhou, China. In J Hazard Mater, Jan 2016
Previous work indicates that the anti-androgenic mechanism of p-nitrophenol is complex and may involve several components in the AR signaling pathway, but the molecular details of how p-nitrophenol inhibits AR signaling are still not quite clear.
Sawyers et al., New York City, United States. In Nat Rev Cancer, Dec 2015
During the past 10 years, preclinical studies implicating sustained androgen receptor (AR) signalling as the primary driver of castration-resistant prostate cancer (CRPC) have led to the development of novel agents targeting the AR pathway that are now in widespread clinical use.
Ustun et al., Bolu, Turkey. In Oncol Lett, Dec 2015
The aim of the present study was to compare cluster of differentiation 10 (CD10) and androgen receptor (AR) expression patterns in BCC and TE, to investigate the predictive power of these proteins as markers of the two conditions.
Jänne et al., Helsinki, Finland. In Endocr Rev, Aug 2015
The physiological androgens testosterone and 5α-dihydrotestosterone regulate the development and maintenance of primary and secondary male sexual characteristics through binding to the androgen receptor (AR), a ligand-dependent transcription factor.
Miyamoto et al., Baltimore, United States. In Dis Markers, 2014
These receptors include androgen receptor, estrogen receptors, glucocorticoid receptor, progesterone receptor, vitamin D receptor, retinoid receptors, peroxisome proliferator-activated receptors, and others including orphan receptors.
Halpern et al., Baltimore, United States. In Dev Dyn, 2008
ar was expressed in discrete regions of the telencephalon, in the preoptic area, and throughout the periventricular hypothalamus, regions previously implicated in the regulation of sexually dimorphic behaviors in mammals